Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.0001 USD | +9’900.00% | -.--% | -83.33% |
Kurzporträt
Mitarbeiterzahl: 33
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01.06.16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Derek Theriault
PRN | Corporate Officer/Principal | - | - |
Dania Scott
PRN | Corporate Officer/Principal | - | 04.09.20 |
Aurelia de Pauw
PRN | Corporate Officer/Principal | - | 01.10.18 |
Steeve Néron
PRN | Corporate Officer/Principal | - | 13.11.18 |
Corporate Officer/Principal | - | 05.06.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01.06.16 |
Catherine Auld
BRD | Director/Board Member | - | 28.05.21 |
H. Norton
CHM | Chairman | 63 | 17.09.20 |
Director/Board Member | 68 | 17.09.20 | |
John Kim
BRD | Director/Board Member | - | 28.05.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 515 634 205 | 510 507 769 ( 99,01 %) | 0 | 99,01 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
-83.33% | 51’563 | |
+37.12% | 6.02 Mrd. | |
-22.80% | 4.19 Mrd. | |
+5.44% | 3.25 Mrd. | |
-19.45% | 2.87 Mrd. | |
-10.35% | 2.37 Mrd. | |
+42.72% | 1.89 Mrd. | |
-5.87% | 1.58 Mrd. | |
-18.53% | 1.54 Mrd. | |
-15.33% | 1.5 Mrd. |
- Börse
- Aktien
- A2ASQ8 Aktie
- Unternehmen Tetra Bio-Pharma Inc.